Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 47,659 · FY2024 125,109 — 3-yr total 172,768
Georgia Capital is a London-listed (LSE: CGEO) investment holding company with portfolio investments in Georgian healthcare, retail (pharmacy), insurance, beverages, real estate (m2), and renewable energy.
Group parent — controls 3 companies · ownership
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| 576,830 | 687,664 | 123,377 | 166,409 | 151,211 | 230,531 | 78,537 | 271,379 | -10.2% | |
| 2,015,679 | 2,929,669 | 2,468,462 | 3,030,635 | 3,850,655 | 3,251,402 | 3,699,767 | 3,728,223 | +9.2% | |
| TOTAL ASSETS | 2,592,509 | 3,617,333 | 2,591,839 | 3,197,044 | 4,001,866 | 3,481,933 | 3,778,304 | 3,999,602 | +6.4% |
| 485,473 | 505,437 | 5,209 | 531 | 21,767 | 5,421 | 963 | 1,656 | nmf | |
| 1,089,070 | 1,685,284 | 828,433 | 983,223 | 1,098,726 | 681,452 | 413,930 | 432,965 | -12.3% | |
| TOTAL LIABILITIES | 1,574,543 | 2,190,721 | 833,642 | 983,754 | 1,120,493 | 686,873 | 414,893 | 434,621 | -16.8% |
| 1,017,966 | 1,426,612 | 1,758,197 | 2,213,290 | 2,881,373 | 2,795,060 | 3,363,411 | 3,564,981 | +19.6% | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | |||||||||
| Total Debt | 728,569 | 1,689,502 | 826,582 | 981,205 | 1,096,256 | 681,452 | 414,002 | 432,965 | -7.2% |
| Cash & Equivalents | 346,239 | 253,349 | 117,215 | 117,026 | 89,714 | 199,771 | 51,138 | 167,801 | -9.8% |
| Net Debt | 382,330 | 1,436,153 | 709,367 | 864,179 | 1,006,542 | 481,681 | 362,864 | 265,164 | -5.1% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →